Viveve Medical (NASDAQ:VIVE) Releases Earnings Results, Beats Estimates By $2.49 EPS

Viveve Medical (NASDAQ:VIVE) issued its quarterly earnings results on Thursday. The company reported ($13.51) earnings per share for the quarter, beating analysts’ consensus estimates of ($16.00) by $2.49, Fidelity Earnings reports. Viveve Medical had a negative return on equity of 2,976.15% and a negative net margin of 341.01%.

NASDAQ VIVE traded down $0.52 on Friday, reaching $3.96. The stock had a trading volume of 244,500 shares, compared to its average volume of 221,374. The business has a 50 day moving average price of $4.73 and a 200 day moving average price of $1.47. Viveve Medical has a 1 year low of $3.13 and a 1 year high of $250.00. The company has a market capitalization of $7.18 million, a price-to-earnings ratio of -0.02 and a beta of 0.14.

A number of research analysts have commented on VIVE shares. Raymond James downgraded Viveve Medical from an “outperform” rating to a “market perform” rating in a research note on Tuesday, July 23rd. Mizuho downgraded Viveve Medical from a “buy” rating to an “underperform” rating and lowered their target price for the company from $4.00 to $0.20 in a research note on Tuesday, July 23rd. Maxim Group restated a “hold” rating on shares of Viveve Medical in a research note on Friday, August 9th. Stifel Nicolaus downgraded Viveve Medical from a “buy” rating to a “hold” rating and lowered their target price for the company from $3.00 to $1.00 in a research note on Monday, July 22nd. Finally, LADENBURG THALM/SH SH downgraded Viveve Medical from a “buy” rating to a “neutral” rating in a research note on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $2.24.

In other Viveve Medical news, major shareholder Goldman Sachs Group Inc sold 92,425 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $4.81, for a total value of $444,564.25. Insiders own 5.20% of the company’s stock.

About Viveve Medical

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.

Further Reading: What are defining characteristics of a correction?

Earnings History for Viveve Medical (NASDAQ:VIVE)

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.